<div id="readability-page-1"><p>Allspring Global Investments Holdings LLC lifted its stake in shares of  Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 29.9% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 717,162 shares of the company's stock after buying an additional 165,240 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.27% of Ryan Specialty worth $39,064,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Ryan Specialty</strong> alerts:</span></p></div><ul><li>3 2021 IPOs Likely To Notch Further Big Price Gains </li></ul><p>Several other hedge funds and other institutional investors have also modified their holdings of the stock. Golden State Wealth Management LLC grew its stake in  Ryan Specialty by 10,975.0% in the 2nd quarter. Golden State Wealth Management LLC now owns 443 shares of the company's stock valued at $30,000 after buying an additional 439 shares during the last quarter.  Central Pacific Bank Trust Division bought a new stake in shares of  Ryan Specialty during the second quarter worth approximately $31,000.  MAI Capital Management boosted its holdings in shares of  Ryan Specialty by 65.3% during the second quarter. MAI Capital Management now owns 476 shares of the company's stock worth $32,000 after acquiring an additional 188 shares during the period.  Quarry LP grew its position in shares of  Ryan Specialty by 977.8% in the first quarter. Quarry LP now owns 582 shares of the company's stock valued at $43,000 after purchasing an additional 528 shares during the last quarter.  Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of  Ryan Specialty in the second quarter valued at approximately $56,000. Institutional investors own  84.82% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>Several analysts recently weighed in on the company. Keefe, Bruyette &amp; Woods dropped their price target on Ryan Specialty from $73.00 to $65.00 and set an &#34;outperform&#34; rating for the company in a report on Monday, November 3rd. UBS Group lowered their price objective on Ryan Specialty from $80.00 to $75.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, October 8th. BMO Capital Markets reduced their target price on shares of Ryan Specialty from $70.00 to $66.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, November 3rd. Mizuho assumed coverage on shares of Ryan Specialty in a research note on Monday, December 15th. They issued a &#34;neutral&#34; rating and a $61.00 price target on the stock. Finally, Barclays lowered their price target on shares of Ryan Specialty from $70.00 to $65.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday, November 20th. One equities research analyst  has rated the stock with a Strong Buy rating, ten have issued  a Buy rating, six have issued  a Hold rating and one  has assigned  a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $65.88.</p><p><b>Read Our Latest Analysis on RYAN</b></p><h2>Insider Buying and Selling at Ryan Specialty</h2><p>In related news, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the sale, the chief executive officer owned 12,553 shares in the company, valued at approximately $672,966.33. This trade represents a 91.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own  52.21% of the company's stock. </p><h2>Ryan Specialty Stock Performance</h2><p>RYAN opened at $50.56 on Friday. The company has a debt-to-equity ratio of 2.72, a quick ratio of 1.00 and a current ratio of 1.00. Ryan Specialty Holdings Inc. has a 52-week low of $50.08 and a 52-week high of $77.16. The firm has a market cap of $13.34 billion, a P/E ratio of 109.91, a price-to-earnings-growth ratio of 1.21 and a beta of 0.63. The business's fifty day moving average is $54.68 and its 200-day moving average is $57.72. </p><p>Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.47 EPS for the quarter, meeting analysts' consensus estimates of $0.47. The business had revenue of $754.58 million during the quarter, compared to the consensus estimate of $742.35 million. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.Ryan Specialty's revenue for the quarter was up 24.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.41 earnings per share.  Sell-side analysts expect that  Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year. </p><h2>Ryan Specialty Announces Dividend</h2><p>The company also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Stockholders of record on Tuesday, November 11th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, November 10th. Ryan Specialty's dividend payout ratio  is 104.35%. </p><h2>About Ryan Specialty</h2> (Free Report)<p>Ryan Specialty Group, Inc <span>NYSE: RYAN<span></span></span> is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients' unique needs.  </p><p>Ryan Specialty's core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Ryan Specialty</li><li>Do not delete, read immediately</li><li>The $100 Trillion AI Story No One Is Telling You</li><li>If You Keep Cash In A U.S. Bank Account… Read This NOW</li><li>But this $2 Gold Stock Before May 20, 2026</li><li>3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax</li></ul><p><strong>Want to see what other hedge funds are holding RYAN?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJZQU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJZQU4"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Ryan Specialty Right Now?</h2><p>Before you consider Ryan Specialty, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.</p><p>While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RYAN

<p>Allspring Global Investments Holdings LLC increased its stake in Ryan Specialty Holdings Inc. by 29.9% in Q3, owning 717,162 shares valued at $39.06 million. Other institutional investors also modified their holdings. Analysts have adjusted price targets, with Keefe, Bruyette & Woods lowering theirs from $73 to $65, while UBS Group reduced theirs from $80 to $75. The stock has an average rating of "Moderate Buy" and a price target of $65.88. CEO Timothy Turner sold 129,570 shares recently, reducing his position significantly.</p>

Allspring Global Investments Holdings LLC Has $39.06 Million Position in Ryan Specialty Holdings Inc. $RYAN